The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 30, 2023

Filed:

Aug. 09, 2017
Applicant:

President and Fellows of Harvard College, Cambridge, MA (US);

Inventors:

David R. Liu, Lexington, MA (US);

Brian Chaikind, Oakland, CA (US);

Jeffrey L. Bessen, Somerville, MA (US);

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12N 9/12 (2006.01); C07K 4/00 (2006.01); C12N 9/22 (2006.01); C12N 15/113 (2010.01);
U.S. Cl.
CPC ...
C12N 9/1241 (2013.01); C07K 4/00 (2013.01); C12N 9/22 (2013.01); C12N 15/113 (2013.01); C07K 2319/09 (2013.01); C07K 2319/21 (2013.01); C07K 2319/43 (2013.01); C12N 2310/20 (2017.05); C12N 2320/11 (2013.01); C12Y 207/07 (2013.01);
Abstract

Some aspects of this disclosure provide a fusion protein comprising a guide nucleotide sequence-programmable DNA binding protein domain (e.g., a nuclease-inactive variant of Cas9 such as dCas9), an optional linker, and a recombinase catalytic domain (e.g., a tyrosine recombinase catalytic domain or a serine recombinase catalytic domain such as a Gin recombinase catalytic domain). This fusion protein can recombine DNA sites containing a minimal recombinase core site flanked by guide RNA-specified sequences. The instant disclosure represents a step toward programmable, scarless genome editing in unmodified cells that is independent of endogenous cellular machinery or cell state.


Find Patent Forward Citations

Loading…